Osi Agrees To Astellas’ Sweetened $4bn Offer

Astellas Pharma, the Japanese drugmaker, has agreed to buy OSI for $4bn in cash, after raising its initial offer for the US-based oncology specialist, by more than 10 per cent

Topics:  astellas pharma   japanese   osi   us-based   offer   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News